Company: TGNT
Filing Date: 2025-11-17
Form Type: 10-Q
Source: 0001477932-25-008363
Chunk: 91

Company: Totaligent, Inc.
Filing Date: 2025-11-17
Form: 10-Q
Item: Part I, Item 8
Chunk 91
---
  2024        Convertible notes payable  80,026,663   37,702,759 Preferred stock  713,750,000   713,750,000 Total  793,776,663   751,452,759  As of September 30, 2025 and 2024,, the number of outstanding common stock plus common stock equivalents is greater than the authorized shares. However, as of September 30, 2025 and 2024, the CEO has enough voting control to increase the number of authorized shares without a full shareholder vote, and is willing to do so if needed. Segment Reporting The Company has determined that it has one reportable segment, which includes managing branding and awareness campaigns to publicly traded companies and political candidates. The single segment was identified based on how the Chief Operating Decision Maker, who was determined to be the Chief Executive Officer, manages and evaluates performance and allocates resources.  Recently accounting pronouncements In November 2023, the FASB issued ASU 2023-07, *Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures*, enhancing segment expense transparency. The update requires public entities to disclose significant segment expenses regularly provided to the chief operating decision maker and extends certain annual segment disclosures to interim periods. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, with interim period application required starting after December 15, 2024, and early adoption permitted. The Company adopted this guidance on January 1, 2024. The Company does not expect any of the recently issued accounting pronouncements to have a material impact on its financial condition or results of operations for the quarter ended as of September 30, 2025 or on a going forward basis. The Company has reviewed all the recently issued, but not yet effective, accounting pronouncements and do not believe any of these pronouncements will have a material impact on its unaudited consolidated financial statements.

 F-12Table of Contents

3. Marketable securities The Company’s marketable securities are stated at fair value in accordance with ASC Topic 321, Investments- Equity Securities.  Any changes in the fair value of the Company’s marketable securities are included in net income under the caption of gain (loss) on change in fair value of securities. The market value of the securities is determined using prices as reflected on an established